arrow
R

Raja Padidela

royal manchester childrens hospital
H指数:28
被引数:3,189

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Complexity of genomic diagnosis: Lessons learnt from the UK Biobank and Generation study newborn genome sequencing analyses” [Bone 212 (2026) 118009]

对“基因组诊断的复杂性:从英国生物银行和Generation研究的新生儿基因组测序分析中汲取的教训”[Bone 212 (2026) 118009]的勘误

Bone
IF3.6
2026-11-030
PRE
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period

Burosumab与X连锁低磷血症患儿的常规治疗: 开放标签,3期延长期的结果

2024-01-043
OAAI
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level

Burosumab与磷酸盐/活性维生素d在小儿X连锁低磷血症中的作用: 剂量水平的亚组分析

2023-04-219
OA
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

与常规疗法相比,Burosumab对X连锁低磷血症的年龄较小和年龄较大的儿童的影响

2022-05-0945
OA
Zoledronic Acid vs Placebo in Pediatric Glucocorticoid-induced Osteoporosis: A Randomized, Double-blind, Phase 3 Trial
2021-07-0624
OA
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
2021-01-2331
OAAI